Genome-wide association study of antibody response to smallpox vaccine

Vaccine

Volumn 30, Issue 28, 2012, Pages 4182-4189

  Ovsyannikova, Inna G ^a   Kennedy, Richard B ^a   O'Byrne, Megan ^a   Jacobson, Robert M ^a   Pankratz, V Shane ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

GWAS; Humoral immunity; Immunogenetics; Smallpox vaccine; SNPs; Vaccinia virus

Indexed keywords

NEUTRALIZING ANTIBODY; SMALLPOX VACCINE;

ADULT; ANKLE 2 GENE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CYP 2C9 GENE; DRUG RESPONSE; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENETICS; KIF 6 GENE; MAJOR CLINICAL STUDY; MALE; PCDH 15 GENE; PRIORITY JOURNAL; PRKCQ GENE; PROMOTER REGION; PSEUDOGENE; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SMALLPOX;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; COHORT STUDIES; ETHNIC GROUPS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SMALLPOX; SMALLPOX VACCINE; YOUNG ADULT;

EID: 84861715100     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.055     Document Type: Article

References (38)

1. Bourzac K. Smallpox: historical review of a potential bioterrorist tool. Journal of Young Investigators 2002, (3).
2. Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., et al. Smallpox as a biological weapon: medical and public health management. JAMA: The Journal of the American Medical Association 1999, 281(June (22)):2127-2137.
3. Cono J., Casey C.G., Bell D.M. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR: Recommendations and Reports 2003, 52(February (RR-4)):1-28.
4. Stanley S.L., Frey S.E., Taillon-Miller P., Guo J., Miller R.D., Koboldt D.C., et al. The immunogenetics of smallpox vaccination. Journal of Infectious Diseases 2007, 196(July (2)):212-219.
5. Reif D.M., McKinney B.A., Motsinger A.A., Chanock S.J., Edwards K.M., Rock M.T., et al. Genetic basis for adverse events after smallpox vaccination. Journal of Infectious Diseases 2008, 198(May (1)):16-22.
6. Poland G.A., Ovsyannikova I.G., Jacobson R.M., Smith D.I. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clinical Pharmacology and Therapeutics 2007, 82(December (6)):653-664.
7. Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. Journal of Infectious Diseases 2011, 203(June (11)):1546-1555.
8. Haralambieva I.H., Ovsyannikova I.G., Dhiman N., Kennedy R.B., O'Byrne M., Pankratz V.S., et al. Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African-Americans. Journal of Infectious Diseases 2011, 204(August (3)):433-441.
9. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(June (7145)):661-678.
10. Hirschhorn J.N., Daly M.J. Genome-wide association studies for common diseases and complex traits. Genetics 2005, 6(February (2)):95-108.
11. Kennedy R.B., Ovsyannikova I.G., Pankratz V.S., Vierkant R.A., Jacobson R.M., Ryan M.A., et al. Gender effects on humoral immune responses to smallpox vaccine. Vaccine 2009, 27(May (25-26)):3319-3323.
12. Manischewitz J., King L.R., Bleckwenn N.A., Shiloach J., Taffs R., Merchlinsky M., et al. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. Journal of Infectious Diseases 2003, 188(August (3)):440-448.
13. Kennedy R., Pankratz V.S., Swanson E., Watson D., Golding H., Poland G.A. Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high throughput assay. Clinical and Vaccine Immunology 2009, 16(June (8)):1105-1112.
14. Huber P.J. Robust regression: asymptotics, conjectures and Monte Carlo. The Annals of Statistics 1973, 1(5):799-821.
15. Schaid D.J., Batzler A.J., Jenkins G.D., Hildebrandt M.A. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. American Journal of Human Genetics 2006, 79(December (6)):1071-1080.
16. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 2006, 38(August (8)):904-909.
17. Devlin B., Roeder K. Genomic control for association studies. Biometrics 1999, 55(December (4)):997-1004.
18. R Software (Computer Program).R Development Core Team R: a language and environment for statistical computing 2011, R Foundation for Statistical Computing, Vienna, Austria, URL. http://www.r-project.org/.
19. Ito Y., Toriuchi N., Yoshitaka T., Ueno-Kudoh H., Sato T., Yokoyama S., et al. The Mohawk homeobox gene is a critical regulator of tendon differentiation. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(June (23)):10538-10542.
20. Oka D., Yamashita S., Tomioka T., Nakanishi Y., Kato H., Kaminishi M., et al. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 2009, 115(August (15)):3412-3426.
21. Kawata H., Yamada K., Shou Z., Mizutani T., Yazawa T., Yoshino M., et al. Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor. Biochemical Journal 2003, 373(August (Pt. 3)):747-757.
22. Peterson M.L., Ma C., Spear B.T. Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer. Seminars in Cancer Biology 2011, 21(February (1)):21-27.
23. Gargalovic P.S., Erbilgin A., Kohannim O., Pagnon J., Wang X., Castellani L., et al. Quantitative trait locus mapping and identification of Zhx2 as a novel regulator of plasma lipid metabolism. Circulation: Cardiovascular Genetics 2010, 3(February (1)):60-67.
24. Kerkhoff E., Simpson J.C., Leberfinger C.B., Otto I.M., Doerks T., Bork P., et al. The Spir actin organizers are involved in vesicle transport processes. Current Biology 2001, 11(December (24)):1963-1968.
25. Aller E., Jaijo T., Garcia-Garcia G., Aparisi M.J., Blesa D., Díaz-Llopis M., et al. Identification of large rearrangements of the PCDH15 gene by combined MLPA and a CGH: large duplications are responsible for Usher syndrome. Investigative Ophthalmology and Visual Science 2010, 51(November (11)):5480-5485.
26. Huertas-Vazquez A., Plaisier C.L., Geng R., Haas B.E., Lee J., Greevenbroek M.M., et al. A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia. Human Genetics 2010, 127(January (1)):83-89.
27. Jacobson S.G., Cideciyan A.V., Aleman T.S., Sumaroka A., Roman A.J., Gardner L.M., et al. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Human Molecular Genetics 2008, 17(August (15)):2405-2415.
28. Cannons J.L., Wu J.Z., Gomez-Rodriguez J., Zhang J., Dong B., Liu Y., et al. Biochemical and genetic evidence for a SAP-PKC-theta interaction contributing to IL-4 regulation. Journal of Immunology 2010, 185(September (5)):2819-2827.
29. Iakoubova O., Shepherd J., Sacks F. Association of the 719Arg variant of KIF6 with both increased risk of coronary events and with greater response to statin therapy. Journal of the American College of Cardiology 2008, 51(June (22)):2195-2196.
30. Iakoubova O.A., Sabatine M.S., Rowland C.M., Tong C.H., Catanese J.J., Ranade K., et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. Journal of the American College of Cardiology 2008, 51(January (4)):449-455.
31. Rettie A.E., Jones J.P. Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. Annual Review of Pharmacology and Toxicology 2005, 45:477-494.
32. 2+ channel subtypes and pharmacology in the kidney. Circulation Research 2007, 100(February (3)):342-353.
33. Adeyemo A., Gerry N., Chen G., Herbert A., Doumatey A., Huang H., et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genetics 2009, 5(July (7)):e1000564.
34. Halsell J.S., Riddle J.R., Atwood J.E., Gardner P., Shope R., Poland G.A., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA: The Journal of the American Medical Association 2003, 289:3283-3289.
35. Maragh S., Miller R.A., Bessling S.L., McGaughey D.M., Wessels M.W., de Graaf B., et al. Identification of RNA binding motif proteins essential for cardiovascular development. BMC Developmental Biology 2011, 11(October (1)):62.
36. Dubucquoi S., Desreumaux P., Janin A., Klein O., Goldman M., Tavernier J., et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. Journal of Experimental Medicine 1994, 179(February (2)):703-708.
37. Takaki S., Kanazawa H., Shiiba M., Takatsu K. A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Molecular and Cellular Biology 1994, 14(November (11)):7404-7413.
38. Dijkhuizen T., van Essen T., van der Vlies P., Verheij J.B., Sikkema-Raddatz B., van der Veen A.Y., et al. FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions. American Journal of Medical Genetics Part A 2006, 140(November (22)):2482-2487.